Leerink Partnrs Has Negative Estimate for WBA Q1 Earnings

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Research analysts at Leerink Partnrs lowered their Q1 2025 earnings estimates for Walgreens Boots Alliance in a report released on Tuesday, December 17th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will earn $0.34 per share for the quarter, down from their prior estimate of $0.40. The consensus estimate for Walgreens Boots Alliance’s current full-year earnings is $1.53 per share. Leerink Partnrs also issued estimates for Walgreens Boots Alliance’s Q3 2025 earnings at $0.35 EPS, Q4 2025 earnings at $0.35 EPS, FY2025 earnings at $1.52 EPS, FY2026 earnings at $1.49 EPS, FY2027 earnings at $1.63 EPS and FY2028 earnings at $1.73 EPS.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter last year, the business posted $0.67 earnings per share. The firm’s revenue was up 5.9% compared to the same quarter last year.

Several other research analysts also recently weighed in on WBA. JPMorgan Chase & Co. lowered their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, August 30th. Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. Truist Financial reduced their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Morgan Stanley cut their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Finally, Royal Bank of Canada dropped their target price on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research report on Wednesday, December 4th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $12.58.

Walgreens Boots Alliance Trading Down 3.6 %

Shares of NASDAQ:WBA opened at $9.35 on Friday. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. Walgreens Boots Alliance has a 52 week low of $8.08 and a 52 week high of $27.05. The company has a market cap of $8.08 billion, a PE ratio of -0.93, a P/E/G ratio of 1.36 and a beta of 0.66. The company’s 50 day moving average is $9.33 and its two-hundred day moving average is $10.59.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 10.70%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s payout ratio is -9.99%.

Institutional Investors Weigh In On Walgreens Boots Alliance

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Principal Financial Group Inc. increased its holdings in shares of Walgreens Boots Alliance by 2.9% during the 3rd quarter. Principal Financial Group Inc. now owns 886,144 shares of the pharmacy operator’s stock worth $7,940,000 after acquiring an additional 24,974 shares during the last quarter. B. Riley Wealth Advisors Inc. lifted its position in Walgreens Boots Alliance by 145.0% during the third quarter. B. Riley Wealth Advisors Inc. now owns 51,832 shares of the pharmacy operator’s stock worth $456,000 after purchasing an additional 30,675 shares during the period. Franklin Resources Inc. boosted its position in shares of Walgreens Boots Alliance by 54.4% during the 3rd quarter. Franklin Resources Inc. now owns 321,425 shares of the pharmacy operator’s stock worth $2,893,000 after acquiring an additional 113,242 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Walgreens Boots Alliance during the third quarter worth about $92,000. Finally, Sanctuary Advisors LLC increased its position in Walgreens Boots Alliance by 79.0% during the 3rd quarter. Sanctuary Advisors LLC now owns 46,333 shares of the pharmacy operator’s stock worth $401,000 after purchasing an additional 20,450 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.